2023-01-012023-12-312023-12-31false08327508METOCEANOLOGY LIMITED2024-03-2974909iso4217:GBPxbrli:pure083275082023-01-01083275082023-12-31083275082023-01-012023-12-31083275082022-01-01083275082022-12-31083275082022-01-012022-12-3108327508bus:SmallEntities2023-01-012023-12-3108327508bus:AuditExempt-NoAccountantsReport2023-01-012023-12-3108327508bus:FullAccounts2023-01-012023-12-3108327508bus:PrivateLimitedCompanyLtd2023-01-012023-12-3108327508core:WithinOneYear2023-12-3108327508core:AfterOneYear2023-12-3108327508core:WithinOneYear2022-12-3108327508core:AfterOneYear2022-12-3108327508core:ShareCapital2023-12-3108327508core:SharePremium2023-12-3108327508core:RevaluationReserve2023-12-3108327508core:OtherReservesSubtotal2023-12-3108327508core:RetainedEarningsAccumulatedLosses2023-12-3108327508core:ShareCapital2022-12-3108327508core:SharePremium2022-12-3108327508core:RevaluationReserve2022-12-3108327508core:OtherReservesSubtotal2022-12-3108327508core:RetainedEarningsAccumulatedLosses2022-12-3108327508core:LandBuildings2023-12-3108327508core:PlantMachinery2023-12-3108327508core:Vehicles2023-12-3108327508core:FurnitureFittings2023-12-3108327508core:OfficeEquipment2023-12-3108327508core:NetGoodwill2023-12-3108327508core:IntangibleAssetsOtherThanGoodwill2023-12-3108327508core:ListedExchangeTraded2023-12-3108327508core:UnlistedNon-exchangeTraded2023-12-3108327508core:LandBuildings2022-12-3108327508core:PlantMachinery2022-12-3108327508core:Vehicles2022-12-3108327508core:FurnitureFittings2022-12-3108327508core:OfficeEquipment2022-12-3108327508core:NetGoodwill2022-12-3108327508core:IntangibleAssetsOtherThanGoodwill2022-12-3108327508core:ListedExchangeTraded2022-12-3108327508core:UnlistedNon-exchangeTraded2022-12-3108327508core:LandBuildings2023-01-012023-12-3108327508core:PlantMachinery2023-01-012023-12-3108327508core:Vehicles2023-01-012023-12-3108327508core:FurnitureFittings2023-01-012023-12-3108327508core:OfficeEquipment2023-01-012023-12-3108327508core:NetGoodwill2023-01-012023-12-3108327508core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3108327508core:ListedExchangeTraded2023-01-012023-12-3108327508core:UnlistedNon-exchangeTraded2023-01-012023-12-3108327508core:MoreThanFiveYears2023-01-012023-12-3108327508core:Non-currentFinancialInstruments2023-12-3108327508core:Non-currentFinancialInstruments2022-12-3108327508dpl:CostSales2023-01-012023-12-3108327508dpl:DistributionCosts2023-01-012023-12-3108327508core:LandBuildings2023-01-012023-12-3108327508core:PlantMachinery2023-01-012023-12-3108327508core:Vehicles2023-01-012023-12-3108327508core:FurnitureFittings2023-01-012023-12-3108327508core:OfficeEquipment2023-01-012023-12-3108327508dpl:AdministrativeExpenses2023-01-012023-12-3108327508core:NetGoodwill2023-01-012023-12-3108327508core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3108327508dpl:GroupUndertakings2023-01-012023-12-3108327508dpl:ParticipatingInterests2023-01-012023-12-3108327508dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3108327508core:ListedExchangeTraded2023-01-012023-12-3108327508dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3108327508core:UnlistedNon-exchangeTraded2023-01-012023-12-3108327508dpl:CostSales2022-01-012022-12-3108327508dpl:DistributionCosts2022-01-012022-12-3108327508core:LandBuildings2022-01-012022-12-3108327508core:PlantMachinery2022-01-012022-12-3108327508core:Vehicles2022-01-012022-12-3108327508core:FurnitureFittings2022-01-012022-12-3108327508core:OfficeEquipment2022-01-012022-12-3108327508dpl:AdministrativeExpenses2022-01-012022-12-3108327508core:NetGoodwill2022-01-012022-12-3108327508core:IntangibleAssetsOtherThanGoodwill2022-01-012022-12-3108327508dpl:GroupUndertakings2022-01-012022-12-3108327508dpl:ParticipatingInterests2022-01-012022-12-3108327508dpl:GroupUndertakingscore:ListedExchangeTraded2022-01-012022-12-3108327508core:ListedExchangeTraded2022-01-012022-12-3108327508dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-01-012022-12-3108327508core:UnlistedNon-exchangeTraded2022-01-012022-12-3108327508core:NetGoodwill2023-12-3108327508core:IntangibleAssetsOtherThanGoodwill2023-12-3108327508core:LandBuildings2023-12-3108327508core:PlantMachinery2023-12-3108327508core:Vehicles2023-12-3108327508core:FurnitureFittings2023-12-3108327508core:OfficeEquipment2023-12-3108327508core:AfterOneYear2023-12-3108327508core:WithinOneYear2023-12-3108327508core:ListedExchangeTraded2023-12-3108327508core:UnlistedNon-exchangeTraded2023-12-3108327508core:ShareCapital2023-12-3108327508core:SharePremium2023-12-3108327508core:RevaluationReserve2023-12-3108327508core:OtherReservesSubtotal2023-12-3108327508core:RetainedEarningsAccumulatedLosses2023-12-3108327508core:NetGoodwill2022-12-3108327508core:IntangibleAssetsOtherThanGoodwill2022-12-3108327508core:LandBuildings2022-12-3108327508core:PlantMachinery2022-12-3108327508core:Vehicles2022-12-3108327508core:FurnitureFittings2022-12-3108327508core:OfficeEquipment2022-12-3108327508core:AfterOneYear2022-12-3108327508core:WithinOneYear2022-12-3108327508core:ListedExchangeTraded2022-12-3108327508core:UnlistedNon-exchangeTraded2022-12-3108327508core:ShareCapital2022-12-3108327508core:SharePremium2022-12-3108327508core:RevaluationReserve2022-12-3108327508core:OtherReservesSubtotal2022-12-3108327508core:RetainedEarningsAccumulatedLosses2022-12-3108327508core:NetGoodwill2022-01-0108327508core:IntangibleAssetsOtherThanGoodwill2022-01-0108327508core:LandBuildings2022-01-0108327508core:PlantMachinery2022-01-0108327508core:Vehicles2022-01-0108327508core:FurnitureFittings2022-01-0108327508core:OfficeEquipment2022-01-0108327508core:AfterOneYear2022-01-0108327508core:WithinOneYear2022-01-0108327508core:ListedExchangeTraded2022-01-0108327508core:UnlistedNon-exchangeTraded2022-01-0108327508core:ShareCapital2022-01-0108327508core:SharePremium2022-01-0108327508core:RevaluationReserve2022-01-0108327508core:OtherReservesSubtotal2022-01-0108327508core:RetainedEarningsAccumulatedLosses2022-01-0108327508core:AfterOneYear2023-01-012023-12-3108327508core:WithinOneYear2023-01-012023-12-3108327508core:Non-currentFinancialInstrumentscore:CostValuation2023-01-012023-12-3108327508core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-012023-12-3108327508core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-012023-12-3108327508core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-012023-12-3108327508core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-012023-12-3108327508core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-012023-12-3108327508core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3108327508core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3108327508core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3108327508core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3108327508core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3108327508core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3108327508core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3108327508core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3108327508core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3108327508core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3108327508core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3108327508core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3108327508core:Non-currentFinancialInstrumentscore:CostValuation2022-12-3108327508core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-12-3108327508core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-12-3108327508core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-12-3108327508core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-12-3108327508core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-12-3108327508core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-12-3108327508core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-12-3108327508core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-12-3108327508bus:Director12023-01-012023-12-3108327508bus:Director22023-01-012023-12-31083275081bus:Director12023-01-01083275081bus:Director12023-01-012023-12-31083275081bus:Director12023-12-31083275082bus:Director22023-01-01083275082bus:Director22023-01-012023-12-31083275082bus:Director22023-12-31083275082023-01-01083275082023-01-012023-12-31083275082023-12-31

METOCEANOLOGY LIMITED

Registered Number
08327508
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2023

METOCEANOLOGY LIMITED
Company Information
for the year from 1 January 2023 to 31 December 2023

Directors

REDFORD, Stephen
VENSKE, Taryn

Registered Address

17 William Morris Way
Tadpole Garden Village
Swindon
SN25 2PP

Registered Number

08327508 (England and Wales)
METOCEANOLOGY LIMITED
Statement of Financial Position
31 December 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets319253
19253
Current assets
Debtors5,84712,305
Cash at bank and on hand1,0772,525
6,92414,830
Creditors amounts falling due within one year4(22,196)(29,405)
Net current assets (liabilities)(15,272)(14,575)
Total assets less current liabilities(15,253)(14,322)
Net assets(15,253)(14,322)
Capital and reserves
Called up share capital100100
Profit and loss account(15,353)(14,422)
Shareholders' funds(15,253)(14,322)
The financial statements were approved and authorised for issue by the Board of Directors on 29 March 2024, and are signed on its behalf by:
REDFORD, Stephen
Director
Registered Company No. 08327508
METOCEANOLOGY LIMITED
Notes to the Financial Statements
for the year ended 31 December 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment3
2.Average number of employees

20232022
Average number of employees during the year22
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 January 23700700
At 31 December 23700700
Depreciation and impairment
At 01 January 23447447
Charge for year234234
At 31 December 23681681
Net book value
At 31 December 231919
At 31 December 22253253
4.Creditors: amounts due within one year

2023

2022

££
Bank borrowings and overdrafts21,89623,333
Taxation and social security-5,098
Accrued liabilities and deferred income300974
Total22,19629,405
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
5.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
REDFORD, Stephen10,16206,4583,704
VENSKE, Taryn13500135
10,29706,4583,839